This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2002 May 4;359(9317):1537-8.

doi: 10.1016/S0140-6736(02)08526-4.

Metastatic colorectal cancer: treatment challenges and quality of life

Andrew Bottomley¹

Affiliations

PMID: 12047959
DOI: 10.1016/S0140-6736(02)08526-4

Comment

Metastatic colorectal cancer: treatment challenges and quality of life

Andrew Bottomley. Lancet. 2002.

. 2002 May 4;359(9317):1537-8.

doi: 10.1016/S0140-6736(02)08526-4.

Author

Andrew Bottomley¹

Affiliation

¹ Quality of Life Unit, European Organisation for Research and Treatment of Cancer, EORTC Data Centre, 1200 Brussels, Belgium. abo@eortc.be

PMID: 12047959
DOI: 10.1016/S0140-6736(02)08526-4

No abstract available

PubMed Disclaimer

Comment on

Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial.
Maughan TS, James RD, Kerr DJ, Ledermann JA, McArdle C, Seymour MT, Cohen D, Hopwood P, Johnston C, Stephens RJ; British MRC Colorectal Cancer Working Party. Maughan TS, et al. Lancet. 2002 May 4;359(9317):1555-63. doi: 10.1016/s0140-6736(02)08514-8. Lancet. 2002. PMID: 12047964 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information